Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Pain. 2011 Aug 23;152(11):2549–2556. doi: 10.1016/j.pain.2011.07.021

Figure 3. PKCε antisense inhibits NLB-induced hyperalgesic priming in muscle.

Figure 3

In adult NLB rats that had received ODN antisense against PKCε for 3 days (filled circles, n=10), PGE2–induced hyperalgesia in the gastrocnemius muscle returned to baseline by 4 h post PGE2, while in mismatch-treated rats (open circles, n=10), PGE2 hyperalgesia remained elevated 24 h after PGE2.